Belantamab mafodotin

Belantamab mafodotin, also known as Blenrep, is a medication used to treat multiple myeloma. It works by acting as a targeted delivery system: a specific part of the medicine finds and attaches to unique markers (called BCMA) found on myeloma cells. Once attached, it releases a powerful agent directly inside these cells, which then stops them from growing and causes them to die. In this topic, you will find information about how Belantamab mafodotin works, what to expect during treatment, and how it fits into your overall care plan. Understanding this treatment can help you feel more informed and supported in your health journey.